2,000% Drug Price Surge Is a Side Effect of FDA Safety ProgramBloombergOct. 06, 2015 |
Mike Johnson Pushes Debunked Lie That Israeli Babies Were 'Cooked in Ovens' On October 7
'Sniper Seen on Roof Overlooking Pro-Palestine Protest' at Indiana University
'It Has to Be Stopped': Netanyahu Demands Pro-Palestine Protests at U.S. Colleges Be Shut Down
Claim Jewish Student Was 'Stabbed In The Eye' by Pro-Palestine Protester Draws Mockery After Video Released
'These Protesters Belong in Jail': Gov. Abbott Cheers Arrest of Pro-Palestine Protesters at UT Austin
Colchicine, a gout remedy so old that the ancient Greeks knew about its effects, used to cost about 25 cents per pill in the U.S. Then in 2010 its price suddenly jumped 2,000 percent. That’s just one of the side effects of a U.S. Food and Drug Administration plan to encourage testing of medicines that have been around longer than the modern FDA itself, and so have never gotten formal approval. Companies that do the tests are rewarded with licenses that can temporarily give them monopoly pricing power as most rivals are eased or kicked off the market. The result has been a surge in the cost of drugs used in treatments from anesthesia to heart surgery and eye operations. Read More |